ロード中...
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
BACKGROUND: Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4(+) T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medication. However, cART initiation at higher CD4 count increases survival, albe...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3491016/ https://ncbi.nlm.nih.gov/pubmed/22943068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2458-12-736 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|